Decoding COPD-related cognitive impairment: The protective potential of YTHDF1

Area of Science:

• Neuroscience
• Pulmonology
• Molecular Biology

Background:

• Cognitive impairment is a major complication of chronic obstructive pulmonary disease (COPD).
• The molecular mechanisms and therapeutic targets for COPD-related cognitive dysfunction are not well understood.
• Cigarette smoke (CS) exposure in COPD models leads to hippocampal damage and memory deficits.

Purpose of the Study:

• To investigate the role of the m6A RNA-binding protein YTHDF1 in COPD-associated cognitive impairment.
• To explore the impact of hypoxia on YTHDF1 expression and hippocampal cell apoptosis in COPD models.
• To determine if YTHDF1 modulation can mitigate CS-induced cognitive deficits.

Main Methods:

• Mice exposed to cigarette smoke (CS) to induce COPD.
• Assessment of cognitive function (working memory, spatial learning) and hippocampal damage.
• Western blot and RT-qPCR to measure YTHDF1 expression.
• In vitro studies using HT22 cells under hypoxic conditions to examine YTHDF1's role in apoptosis.

Main Results:

• CS exposure in COPD mice caused hippocampal damage and impaired cognitive functions.
• YTHDF1 expression was significantly reduced in the hippocampus of COPD mice and under hypoxia.
• Overexpression of YTHDF1 reduced hypoxia-induced apoptosis in HT22 cells and attenuated CS-induced cognitive impairment in mice.

Conclusions:

• YTHDF1 plays a critical role in protecting against cognitive impairment associated with COPD.
• Reduced YTHDF1 levels and hypoxia contribute to hippocampal neuronal apoptosis in COPD.
• YTHDF1 represents a potential therapeutic target for managing cognitive dysfunction in COPD patients.